New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer

Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer